Page last updated: 2024-08-26

22-hydroxycholesterol and rosiglitazone

22-hydroxycholesterol has been researched along with rosiglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alegret, M; Ciudad, CJ; Laguna, JC; Llaverias, G; Noé, V; Sánchez, RM; Vázquez-Carrera, M	1

Other Studies

1 other study(ies) available for 22-hydroxycholesterol and rosiglitazone

Article	Year
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. Journal of lipid research, 2004, Volume: 45, Issue:11 Topics: Anilides; Animals; Apoptosis; Base Sequence; Binding Sites; Blotting, Western; Caspase 3; Caspases; Caveolin 1; Caveolins; CD11b Antigen; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Hydroxycholesterols; Ligands; Liver X Receptors; Macrophages; Molecular Sequence Data; Orphan Nuclear Receptors; PPAR gamma; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Cytoplasmic and Nuclear; RNA; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors; Transcription, Genetic; Up-Regulation; Vasodilator Agents	2004

Article

Year

Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism.

Journal of lipid research, 2004, Volume: 45, Issue:11

Topics: Anilides; Animals; Apoptosis; Base Sequence; Binding Sites; Blotting, Western; Caspase 3; Caspases; Caveolin 1; Caveolins; CD11b Antigen; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Hydroxycholesterols; Ligands; Liver X Receptors; Macrophages; Molecular Sequence Data; Orphan Nuclear Receptors; PPAR gamma; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Cytoplasmic and Nuclear; RNA; RNA, Messenger; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones; Time Factors; Transcription, Genetic; Up-Regulation; Vasodilator Agents

2004